Cytek Biosciences, Inc.
← Back to CTKB Overview

Cytek Biosciences, Inc. (CTKB)

Profitability & Net Margin History

Current Net Margin

-70.93%

Cytek Biosciences, Inc. currently has a net profit margin of -70.93%.

Financial Fundamentals

CTKBQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.06-0.04-70.93%6045
2025-09-300.05-0.01-10.48%177
2025-06-300.05-0.01-12.24%1526
2025-03-310.04-0.01-27.50%4428
2024-12-310.060.0116.78%1495
2024-09-300.050.001.83%2421
2024-06-300.05-0.01-22.38%863
2024-03-310.04-0.01-13.75%2320
2023-12-310.060.019.45%2290
2023-09-300.05-0.01-13.45%462
2023-06-300.05-0.00-8.83%952
2023-03-310.04-0.01-18.35%2565
2022-12-310.050.007.30%319
2022-09-300.040.004.12%560
2022-06-300.04-0.00-1.49%427
2022-03-310.04-0.00-5.76%270
2021-12-310.04-0.00-3.06%719
2021-09-300.030.004.13%465
2021-06-300.030.008.78%836
2021-03-310.020.000.42%1787
2020-12-310.030.0118.29%777
2020-09-300.030.0126.06%1633
2020-06-300.020.0142.39%4705
2020-03-310.02-0.00-4.66%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.